TSRL, Inc.

Prodrug & Infectious Disease | #Preclinical #Accelerator. Non-Dilutive Funding Experts, Driving Value from Lead to Clinic.

[TSRL, Inc. @TSRL_Inc]

TSRL, Inc. Awarded NIH Grant to Develop Microneedle Patch for Treatment of Influenza https://t.co/IjCLk3WZnC

[Dr. Rob @robsleaders]

This Friday at 8 am, Leaders Connect will be presenting "Science-Based Businesses in Times of Transformative Change". If you would like to attend, please sign up on Eventbrite: https://t.co/6cwyu6J4WH

[TSRL, Inc. @TSRL_Inc]

TSRL Announces the Appointments of Martha Farmer and Stephen Munk to Board of Directors, and Gregory Amidon as Chairman of the Board https://t.co/T1V6wFRMBg

[TSRL, Inc. @TSRL_Inc]

TSRL & Investigators awarded $3.6m in NIH funding to develop new antibacterials #preclinical #accelerator https://t.co/ONOuqOTjHT

[TSRL, Inc. @TSRL_Inc]

TSRL & Investigators awarded $3.6m in NIH funding to develop new antibacterials #preclinical #accelerator https://t.co/vfDmDfA3A2

[TSRL, Inc. @TSRL_Inc]

Excited to be attending BIO 2017 this year. Come pay us a visit! Would love to touch base on our #preclinical #accelerator programs.

[TSRL, Inc. @TSRL_Inc]

WHO publishes 12 families of bacteria that pose the greatest health threat. Acinetobacter, Pseudomonas top list https://t.co/68sXDpoiFs

[Julia Belluz @juliaoftoronto]

Interesting (and scary) list today from the WHO on the top superbug threats https://t.co/UucKMuGAi9

[TSRL, Inc. @TSRL_Inc]

TSRL's #preclinical #accelerator is highlighted on Elsevier's January Start-Up Spotlight! @ElsevierConnect https://t.co/UMoB8SUfUu

[TSRL, Inc. @TSRL_Inc]

Great panel on the state of the bio-industry in MI at the #MichbioExpo @michbio

[Kevin Outterson @koutterson]

Excellent review of the economics of antibiotics. Bonus: the patent history of penicillin https://t.co/GRKXhnslg6

[TSRL, Inc. @TSRL_Inc]

Happy Holidays from TSRL! Looking forward to a great 2017!

[Kevin Outterson @koutterson]

2/2 Solution could be market exclusivity for unpatentable antibiotics, well beyond GAIN Act, with clear conditions on access & stewardship

[TSRL, Inc. @TSRL_Inc]

Terrific program conceived by the @NSF. Grateful it is being applied to the @NIH and @CDCgov. Time for #customerdiscovery! https://t.co/PdwXJbWt6w

[SBIRpros @BBC_etc]

I-Corps™ at NIH program for NIH & CDC Ph I #SBIR #STTR grantees. Applications Due: Jan 9, '17. https://t.co/3eAkQWSERJ

[TSRL, Inc. @TSRL_Inc]

Our #preclinical #accelerator is reviewing novel antiviral & antibacterial ideas for #nondilutive #funding opportunities at @NIHsbir

[TSRL, Inc. @TSRL_Inc]

New Report: #infection implicated in 5.4% of all deaths; #influenza & #pneumonia majority of cases https://t.co/gsr2uvwRNZ @JAMA_current

[TSRL, Inc. @TSRL_Inc]

Great event about #recruiting and retaining C-level talent #annarbor @AnnArborSPARK https://t.co/KSCiULM3BQ

[BioArbor @BioArbor]

Did you miss the October BioArbor? Watch 'The Talent Bottleneck: Recruiting Senior Level Management' https://t.co/vUae81lidN

[TSRL, Inc. @TSRL_Inc]

@DrewHertig & Elke Lipka to present Nov 11 at @michiganstateu Seminar Series on TSRL's #preclinical #accelerator https://t.co/EYS9rUJdQu

[TSRL, Inc. @TSRL_Inc]

We need an #antibiotic #stewardship app accessible by patients and doctors alike https://t.co/X92QanWMdB

[IDSA @IDSAInfo]

Twitter and Facebook encourage young med residents to use antibiotic stewardship (ASP) resources, suggests new study https://t.co/5SDE8gvFRT

[Infectious Diseases @InfectiousDz]

This is important news: China banning colistin Nov 1 2016 from food animals. Colistin is a last line drug against resistant bacteria #idweek